paolo gandellini
University of Milan
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
sara gandolfi
CRCI2NA INSERM U1307
Nantes, France
Review Editor
Cancer Molecular Targets and Therapeutics
prakash gangadaran
Kyungpook National University
Daegu, Republic of Korea
Review Editor
Cancer Molecular Targets and Therapeutics
yuen gao
Michigan State University
East Lansing, United States
Review Editor
Cancer Molecular Targets and Therapeutics
ilias georgakopoulos-soares
The Pennsylvania State University (PSU)
University Park, United States
Review Editor
Cancer Molecular Targets and Therapeutics
saeid ghavami
Department of Human Anatomy and Cell Science, Max Rady College of Medicine, University of Manitoba
Winnipag, Canada
Review Editor
Cancer Molecular Targets and Therapeutics
jayeeta ghose
The Ohio State University
Columbus, United States
Review Editor
Cancer Molecular Targets and Therapeutics
arianna giacomini
University of Brescia
Brescia, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
anand giddabasappa
Pfizer
New York, United States
Review Editor
Cancer Molecular Targets and Therapeutics
vasudeva ginjala
Rutgers, The State University of New Jersey
New Brunswick, United States
Review Editor
Cancer Molecular Targets and Therapeutics
ilaria giusti
Department of Life, Health and Environmental Sciences, University of L'Aquila
L’Aquila, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
vasiliki gkretsi
Department of Life Sciences, School of Sciences, European University Cyprus
Nicosia, Cyprus
Review Editor
Cancer Molecular Targets and Therapeutics
moloy goswami
Kellogg Eye Center, School of Medicine, University of Michigan
Ann Arbor, United States
Review Editor
Cancer Molecular Targets and Therapeutics
mohamed gouda
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
dimitris goutas
Department of Pathology, National and Kapodistrian University of Athens Medical School
Athens, Greece
Review Editor
Cancer Molecular Targets and Therapeutics
gabrielle grundy
University of Liverpool
Liverpool, United Kingdom
Review Editor
Cancer Molecular Targets and Therapeutics